Don't Panic, It Might Be a Blister: A Guide to Common Causes and Treatments

Discovering a blister on the vulva (the external genitalia) can be distressing. While some causes are minor and self-limited, others require medical evaluation and treatment. This guide is intended to provide a clinical overview of common causes, diagnostic approaches, management options, prevention strategies, and when to seek care. Information is presented for health education and should not replace individualized medical advice.

Vulvar versus vaginal: definitions and importance

  • Vulva: the external structures — labia majora, labia minora, clitoris, vestibule, and the opening of the urethra and vagina. Blisters on these external areas are best described as vulvar lesions.
  • Vagina: the internal canal. Lesions described as "vaginal" are less visible on external inspection; most blisters that patients notice are on the vulva.

Accurate terminology guides the history-taking and physical exam and helps determine which conditions are more likely.

How vulvar blisters can look

Vulvar blisters (vesicles or bullae) vary by cause:

  • Vesicles: small, fluid-filled lesions (usually <5–10 mm).
  • Bullae: larger fluid-filled blisters.
  • Erythematous (red) or tender blisters may indicate inflammation or infection.
  • Clear, serous, yellowish, or blood-tinged contents can reflect different processes (inflammatory, bacterial, hemorrhagic).
  • Distribution patterns matter: grouped, unilateral vesicles in a dermatomal or localized pattern suggest certain viral infections; diffuse or symmetric eruptions suggest contact dermatitis or systemic dermatologic disease.

Visual description alone often cannot determine the exact cause; context and clinical testing are typically needed.

Common causes of vulvar blisters

Infectious causes

  1. Herpes simplex virus (HSV)
  • HSV-1 and HSV-2 can both cause primary and recurrent vulvar lesions, typically presenting as clusters of painful vesicles that may ulcerate.
  • Initial episodes may be accompanied by systemic symptoms (fever, malaise) and tender inguinal lymphadenopathy.
  • Recurrent episodes tend to be milder and shorter.
  • Diagnosis: viral culture or PCR from lesion swab; type-specific serology can help determine prior exposure [ACOG; NIH] [1,2].
  1. Varicella zoster virus (shingles)
  • Reactivation of varicella zoster virus can cause vesicular eruptions in a dermatomal distribution, sometimes affecting the genital area. Lesions are typically unilateral and painful [NIH] [2].
  1. Molluscum contagiosum
  • A poxvirus that produces small, firm, dome-shaped papules with central umbilication; can appear in the genital area. These are typically not true blisters but may be mistaken for small vesicles [Mayo Clinic] [3].
  1. Bacterial infections
  • Impetigo or secondary bacterial infection of excoriated skin can produce pustules or bullae; cellulitis can complicate a primary lesion and lead to swelling and blistering [Cleveland Clinic] [4].
  1. Fungal infections (vulvovaginal candidiasis)
  • Commonly causes erythema, itching, and satellite papules; small vesiculopustular lesions may occur in severe or recurrent cases [Mayo Clinic] [3].
  1. Sexually transmitted infections (other)
  • Some STIs present with ulcers rather than blisters (e.g., syphilis chancre is typically a painless ulcer). However, initial vesicular lesions are most suggestive of HSV. Evaluation for other STIs is often part of the workup [ACOG] [1].

Inflammatory and dermatologic causes

  1. Contact dermatitis / allergic reaction
  • Topical products (soaps, detergents, spermicides, lubricants, fragrances), fabric softeners, or latex can cause an eczematous reaction. Vesiculation (blisters) can occur in allergic or irritant dermatitis.
  • Location and timing relative to exposure are key diagnostic clues.
  1. Autoimmune blistering disorders
  • Conditions such as bullous pemphigoid and pemphigus vulgaris can affect mucocutaneous surfaces including the vulva; these are uncommon and usually part of a wider presentation requiring dermatology referral and biopsy [NIH] [2].
  1. Lichen planus and lichen sclerosus
  • Chronic dermatoses that may cause erosions, fissures, and discomfort; lichen planus can occasionally produce vesiculobullous lesions [Cleveland Clinic] [4].
  1. Fixed drug eruption
  • Recurrent lesions at the same site following exposure to a systemic medication — may present as well-demarcated erythematous patches that blister.

Mechanical and traumatic causes

  • Friction or pressure from clothing, underwear, sexual activity, or repetitive motion (e.g., cycling) can produce friction blisters.
  • Burns or chemical exposures may also blister the vulvar skin.

Clinical evaluation: what clinicians ask and examine

A careful history and targeted exam usually guide testing and treatment.

Key history elements:

  • Onset, duration, and evolution of lesions.
  • Symptoms: pain, itching, discharge, fever, systemic symptoms.
  • Sexual history: recent new partners, condom use, type of sexual activity, partner symptoms.
  • Recent products or exposures: new hygiene products, laundry detergents, topical medications, perfumes, lubricants.
  • Past similar episodes and prior STI history.
  • Pregnancy, immunosuppression, or chronic conditions (e.g., diabetes).

Physical examination:

  • Visual inspection of the vulva, perineum, and adjoining skin.
  • Characterize lesions: size, number, grouped vs. isolated, unilateral vs. bilateral, presence of ulceration, crusting, or discharge.
  • Check for inguinal lymphadenopathy and signs of systemic infection.
  • Pelvic exam and vaginal discharge assessment when appropriate.

Diagnostic testing

Testing is individualized based on suspected cause:

  • Viral PCR or culture from lesion swab for HSV or varicella zoster; PCR is more sensitive [ACOG, NIH] [1,2].
  • Type-specific HSV serology may be useful in selected cases (to document prior exposure).
  • Bacterial swab and culture if secondary infection or impetigo suspected.
  • KOH preparation or fungal culture for suspected candida.
  • Vaginal pH and testing for bacterial vaginosis (Amsel criteria or NAATs) if discharge and malodor suggest BV.
  • NAAT testing for chlamydia and gonorrhea as part of STI screening.
  • Syphilis serology (RPR with confirmatory treponemal testing) when ulcers or higher-risk exposures exist.
  • Biopsy for persistent, atypical, or refractory lesions when autoimmune or dermatologic disease is suspected [Mayo Clinic; Cleveland Clinic] [3,4].

Treatment options by cause

General supportive care for benign causes (friction, mild contact dermatitis)

  • Avoid the offending irritant (change detergents, stop new topical products).
  • Loose-fitting, breathable cotton underwear; avoid synthetic tight clothing.
  • Cool compresses to soothe irritation.
  • Over-the-counter analgesics for pain control (acetaminophen, NSAIDs unless contraindicated).
  • Barrier creams (zinc oxide, petroleum jelly) to protect areas prone to friction.
  • Oral antihistamines for pruritus.

For mild contact dermatitis:

  • Low- to medium-potency topical corticosteroids for a short course on vulvar skin under medical supervision (use caution due to thin skin; prolonged use can cause atrophy) [Cleveland Clinic] [4].
  • Referral to dermatology for patch testing if allergic contact dermatitis is suspected and the trigger is unclear.

Herpes simplex virus (HSV)

  • Antiviral therapy is effective at reducing duration and severity of outbreaks and can reduce viral shedding.
  • Common agents: acyclovir, valacyclovir, famciclovir.
  • Typical regimens (examples; dosing should be individualized):
  • Initial episode: acyclovir 400 mg orally three times daily or valacyclovir 1 g orally twice daily for 7–10 days (follow institutional or guideline recommendations).
  • Recurrent episodes: shorter courses; early treatment at prodromal symptoms is most effective.
  • Suppressive therapy: daily antiviral therapy (e.g., valacyclovir 500–1000 mg once daily) for people with frequent recurrences or to reduce transmission risk [ACOG; NIH] [1,2].
  • Local wound care: keep lesions clean and dry; cool compresses; avoid topical antivirals unless prescribed.
  • Counseling: avoid sexual activity during active lesions; condoms reduce but do not eliminate transmission risk.

Bacterial cellulitis or secondary bacterial infection

  • Systemic antibiotics directed at the suspected organisms (often streptococci and staphylococci); selection depends on local resistance patterns, severity, and culture results.
  • Incision and drainage only if an abscess is present.
  • Close follow-up for improvement; consider hospitalization if systemic signs, extensive cellulitis, or immunocompromise.

Vulvovaginal candidiasis (yeast infection)

  • Topical antifungals (azoles) or a single dose of oral fluconazole (150 mg) are commonly used for uncomplicated cases [Mayo Clinic] [3].
  • Recurrent or complicated candidiasis may require longer or suppressive therapy and evaluation for predisposing conditions.

Bacterial vaginosis (BV)

  • Metronidazole orally or topical intravaginal regimens are standard treatments. Treat based on clinical criteria and testing [NIH] [2].

Molluscum contagiosum

  • Often self-limited. Treatment options include physical removal (cryotherapy, curettage) or topical therapies; discuss risks and benefits with a clinician.

Autoimmune blistering diseases

  • These require dermatology and potentially immunology consultation.
  • Treatments may include systemic corticosteroids and steroid-sparing immunosuppressive agents depending on diagnosis and severity.

Special considerations in pregnancy

  • Primary HSV infection during pregnancy, particularly near delivery, poses risk for neonatal disease. ACOG recommends suppressive antiviral therapy starting at 36 weeks gestation for patients with a history of genital herpes to reduce outbreaks at delivery. Cesarean delivery may be recommended if active genital lesions or prodromal symptoms are present at the time of labor [ACOG] [1].
  • Many topical agents and systemic medications require careful consideration in pregnancy; consult obstetric care providers before treatment.

Prevention strategies

  • Avoidance of known irritants: fragrance-free, gentle cleansers; select unscented laundry detergents; avoid douching.
  • Barrier methods: condoms can reduce transmission of some infections but do not eliminate risk for infections that involve uncovered skin (e.g., HSV).
  • For individuals with recurrent HSV, daily suppressive antiviral therapy reduces outbreaks and decreases transmission risk.
  • HPV vaccination for eligible individuals reduces risk of HPV-related disease, though HPV typically causes warts rather than blisters [CDC resources—refer to primary sources].
  • Good vulvar hygiene: gentle cleansing with water or mild soap, pat dry rather than rub.
  • Avoidance of tight or non-breathable clothing during symptomatic periods.

When to seek medical attention (red flags)

Seek prompt evaluation if any of the following occur:

  • First episode of genital lesions.
  • Severe pain, inability to urinate, or urinary retention.
  • Fever, chills, or systemic symptoms.
  • Rapidly progressive swelling or redness suggestive of cellulitis.
  • Immunocompromised state (e.g., chemotherapy, HIV, high-dose steroids).
  • Pregnancy, particularly late in pregnancy or near term.
  • Failure to improve with initial home measures or prescribed therapy.
  • Recurrent lesions that significantly impact quality of life.

Emergency care is indicated for signs of systemic infection (sepsis), significant bleeding, or severe urinary obstruction.

Sexual health counseling and partner considerations

  • Open, nonjudgmental communication about diagnosis and transmission risk is important.
  • Partners may require testing for STIs depending on the diagnosis and risk history.
  • Avoid sexual activity during active lesions for conditions known to be transmissible (e.g., HSV); use barrier protection once healed, and consider suppressive therapy to reduce risk.
  • In the case of HSV or other STIs, discuss partner notification and testing per local public health guidance [ACOG] [1].

Follow-up and long-term management

  • For recurrent or atypical lesions, arrange follow-up with primary care, gynecology, or dermatology for further evaluation (biopsy, extended testing).
  • For conditions requiring chronic therapy (recurrent HSV, autoimmune blistering diseases), establish a management plan that balances efficacy and adverse effects.
  • Consider screening for other STIs if indicated by the initial diagnosis or patient history.

Differential diagnosis summary

  • Herpes simplex virus
  • Varicella zoster (shingles)
  • Molluscum contagiosum
  • Impetigo or secondary bacterial infection
  • Vulvovaginal candidiasis
  • Contact dermatitis / allergic dermatitis
  • Autoimmune blistering disorders (e.g., pemphigus, bullous pemphigoid)
  • Fixed drug eruption
  • Dermatologic conditions (lichen planus, lichen sclerosus)
  • Syphilis (typically ulcer rather than blister) — should be considered in the differential of genital lesions

Common myths and misconceptions

  • Myth: All genital blisters are STIs. Reality: Many noninfectious causes (contact dermatitis, friction) can cause blisters.
  • Myth: If a lesion is painless, it’s not serious. Reality: Some serious infections (e.g., syphilis chancre) may be painless; medical evaluation is important.
  • Myth: Condoms prevent all transmission of genital infections. Reality: Condoms reduce but do not eliminate transmission risk of pathogens that affect uncovered skin.

Practical tips for patients

  • Document lesion appearance with dated photographs if comfortable; this can help the clinician assess evolution.
  • Keep a list of products applied to the area and recent exposures.
  • Avoid self-treatment with unverified over-the-counter remedies that may worsen the skin.
  • Use gentle, unscented products on the vulvar area and avoid tight clothing until healed.

When specialists are needed

  • Dermatology: atypical or persistent dermatologic disease, need for biopsy, diagnosis of autoimmune blistering disorders.
  • Infectious disease: complicated or severe infections, unusual pathogens, or when standard therapy fails.
  • Gynecology/Obstetrics: pregnancy-related management, recurrent vulvovaginal conditions, surgical concerns.
  • Urology: urinary retention or significant urinary symptoms.

Key takeaways

  • Vulvar blisters have many possible causes ranging from mechanical friction and allergic reactions to viral and bacterial infections and autoimmune disorders.
  • Accurate history, focused physical exam, and appropriate testing are necessary to determine the cause and guide treatment.
  • Many conditions are treatable; prompt evaluation is indicated for severe symptoms, pregnancy, immunocompromise, or the first episode.
  • Prevention emphasizes avoidance of irritants, safe sexual practices, hygiene, and—for some infections—vaccination or suppressive therapy.

If you discover a blister or other unusual lesion on the vulva, consider contacting your healthcare provider for evaluation. Early assessment can clarify the cause, guide effective treatment, and reduce complications.

References

  1. American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin and Committee Opinions on genital herpes management and pregnancy-related recommendations. Available at: https://www.acog.org/clinical
  2. National Institutes of Health (NIH) — National Institute of Allergy and Infectious Diseases (NIAID). Herpes Simplex Virus Information. Available at: https://www.niaid.nih.gov/diseases-conditions/herpes-simplex
  3. Mayo Clinic. Vaginal yeast infection (vaginal candidiasis) overview; Molluscum contagiosum; Genital wart and lesion information. Available at: https://www.mayoclinic.org
  4. Cleveland Clinic. Contact dermatitis, vulvar skin conditions, and genital lesion evaluation. Available at: https://my.clevelandclinic.org

(For detailed guidance and dosing, consult official clinical practice guidelines or your healthcare provider. The references above provide general patient-oriented information from major clinical authorities.)